每經AI快訊，海(hai)正(zheng)藥業（SH 600267，收盤價：10.42元(yuan)）9月23日晚(wan)間發布公(gong)(gong)(gong)(gong)告(gao)稱，2022年(nian)9月21日，浙(zhe)(zhe)江海(hai)正(zheng)藥業股(gu)(gu)(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)召開第(di)九(jiu)屆董事(shi)會第(di)七次會議(yi)和第(di)九(jiu)屆監事(shi)會第(di)五次會議(yi)，審議(yi)通過了《關于以集(ji)中競價交易方式回購(gou)公(gong)(gong)(gong)(gong)司(si)股(gu)(gu)(gu)份(fen)的(de)議(yi)案》。現將公(gong)(gong)(gong)(gong)司(si)2022年(nian)9月21日前十大無限(xian)售(shou)條件股(gu)(gu)(gu)東(dong)披(pi)露如下：浙(zhe)(zhe)江海(hai)正(zheng)集(ji)團有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)持(chi)(chi)約(yue)(yue)(yue)(yue)3.21億股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)28.93%；HPPC Holding SARL持(chi)(chi)約(yue)(yue)(yue)(yue)7911萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)7.13%；浙(zhe)(zhe)江省國際貿易集(ji)團有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)持(chi)(chi)約(yue)(yue)(yue)(yue)7465萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)6.73%；浙(zhe)(zhe)江海(hai)正(zheng)藥業股(gu)(gu)(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)回購(gou)專用(yong)證券賬戶持(chi)(chi)約(yue)(yue)(yue)(yue)1655萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)1.49%；彭寅(yin)生持(chi)(chi)約(yue)(yue)(yue)(yue)488萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.44%；周(zhou)炳基持(chi)(chi)約(yue)(yue)(yue)(yue)413萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.37%；海(hai)通證券股(gu)(gu)(gu)份(fen)有(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)持(chi)(chi)約(yue)(yue)(yue)(yue)370萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.33%；王(wang)墨(mo)持(chi)(chi)約(yue)(yue)(yue)(yue)367萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.33%；徐德君持(chi)(chi)339萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.31%；張敏(min)持(chi)(chi)約(yue)(yue)(yue)(yue)326萬(wan)股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)0.29%。前十大流(liu)通股(gu)(gu)(gu)東(dong)合計持(chi)(chi)股(gu)(gu)(gu)約(yue)(yue)(yue)(yue)5.14億股(gu)(gu)(gu)，占(zhan)(zhan)比(bi)(bi)(bi)46.35%。

2022年1至6月份(fen)，海正藥(yao)業的營業收(shou)入構成為：醫藥(yao)生產占比(bi)57.17%，藥(yao)品銷售占比(bi)40.43%，CMO/CDMO/CRO業務占比(bi)0.48%，其他行(xing)業占比(bi)0.07%。

海正藥(yao)業的董事長是(shi)蔣(jiang)國平，男(nan)，61歲，學歷(li)背(bei)景(jing)(jing)為(wei)本科；總裁是(shi)李琰，男(nan)，46歲，學歷(li)背(bei)景(jing)(jing)為(wei)碩(shuo)士。

截至發稿，海正藥(yao)業市值為125億元(yuan)。

道達號（daoda1997）“個股趨勢”提醒：
1. 海正藥業近30日內北向資金持股量未發生變化；
2. 近30日內共有1批機構對海正藥業調研，合計調研的機構家數為21家。
更多個股趨勢信(xin)息，請(qing)搜索微信(xin)公眾號“道達號”，回(hui)復“查詢”，領取(qu)免(mian)費查詢權限(xian)！

每(mei)經頭(tou)條（nbdtoutiao）——

(記者 曾健輝)

免責聲明：本文內容(rong)與(yu)數(shu)據僅供參考，不構成投資(zi)建(jian)議，使用前請核(he)實(shi)。據此操作，風險自(zi)擔。